Leksell Vantage stereotactic system safety information
Summary
The French ANSM has issued a safety notice regarding the Leksell Vantage stereotactic system by Elekta Ltd. This action, registered under number R2607991, is based on a safety action implemented by the manufacturer. Affected healthcare facilities have been notified.
What changed
The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety information notice concerning the Leksell Vantage stereotactic system manufactured by Elekta Ltd. The notice, registered under number R2607991, highlights a safety action undertaken by the manufacturer, with details provided in a letter dated March 17, 2026, sent directly to affected healthcare facilities.
Healthcare providers utilizing the Leksell Vantage system should review the safety information and the manufacturer's communication. Any questions should be directed to Elekta Ltd. This notice serves as an alert to potential safety concerns and requires awareness from relevant medical professionals and institutions to ensure patient safety and proper device management.
What to do next
- Review safety information regarding the Leksell Vantage stereotactic system.
- Consult the manufacturer's communication for specific instructions.
- Direct any questions to Elekta Ltd.
Archived snapshot
Mar 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Information n° R2607991 destinée aux établissements de santé L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Elekta Ltd.
Les utilisateurs concernés ont reçu le courrier ci-joint.
Cette action de sécurité est enregistrée à l’ANSM sous le n° R2607991.
Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Consultez le courrier de la société Elekta Ltd (17/03/2026)
Related changes
Get daily alerts for ANSM Drug & Device Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from ANSM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.